Clinical Trial Update: The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study [NA]

View source ↗

Summary

The CorCinch functional mitral regurgitation study sponsored by Ancora Heart has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure
• Mitral Regurgitation

Snippet

Sponsor: Ancora Heart, Inc. | Conditions: Heart Failure, Mitral Valve Insufficiency | NA | Status: COMPLETED